This assay detects the presence of an abnormal clone to indicate malignant neoplastic process. It assists in the diagnosis and classification of certain malignant hematological disorders, evaluation of prognosis, monitoring effects of therapy and remission. Bone marrow specimens are preferred over peripheral blood.